XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.25.2

Equity Method Investments | 12 Months Ended
--- | ---
Mar. 31, 2025
Equity Method Investments and Joint Ventures [Abstract] |
Equity Method Investments | 12. Equity method investments Equity method investments at March 31, 2024 and 2025 consists of the following:
|  | Millions of yen |
|  | 2024 |  |  | 2025 |
Investment in corporate entities |  | ¥ | 1,002,560 |  |  | ¥ | 973,795 |
Investment in real estate joint ventures |  |  | 124,537 |  |  |  | 137,274 |
Investment in partnerships and other investments |  |  | 186,790 |  |  |  | 208,946 |
|  | ¥ | 1,313,887 |  |  | ¥ | 1,320,015 |
Certain equity method investees are listed on stock exchanges. The aggregate investment in and quoted market value of those equity method investees amounted to ¥163,074 million and ¥157,932 million, respectively, as of March 31, 2024 and ¥107,524 million and ¥107,466 million, respectively, as of March 31, 2025. In fiscal 2023, 2024 and 2025, the Company and its subsidiaries received dividends from equity method investees of ¥25,574 million, ¥25,820 million and ¥30,151 million, respectively. In the Company’s consolidated balance sheets, the book value of equity method investments over the underlying equity in the net assets of such equity method investees as of date of the most recent available financial statements of the investees were ¥144,709 million and ¥127,779 million as of March 31, 2024 and 2025, respectively. The basis differences mainly consist of goodwill and fair value adjustments for fixed assets. The basis differences would be amortized and adjusted for impairment, if any, and the changes in the differences are included in equity in net income (loss) of equity method investments. Companies comprising a significant portion of investment in corporate entities were Kansai Airports (40% of equity share), ORIX Credit Corporation ( whi ch changed its name to DOCOMO Finance, Inc on April 1, 2025) (34% of equity share) and Avolon Holdings Limited (30% of equity share) as of March 31, 2024 and 2025. Combined and condensed information relating to the equity method investees for fiscal 2023, 2024 and 2025 are as follows (some operation data for entities reflect only the period since the Company and its subsidiaries made the investment and on a lag basis):
|  | Millions of yen |
|  | 2023 |  |  | 2024 |  |  | 2025 |
Operations: |  |  |  |  |  |  |  |  |  |  |  |
Total revenues |  | ¥ | 1,792,981 |  |  | ¥ | 2,871,734 |  |  | ¥ | 5,799,502 |
Income before income taxes |  |  | (372,994 | ) |  |  | 266,966 |  |  |  | 607,503 |
Net income |  |  | (432,618 | ) |  |  | 198,006 |  |  |  | 420,757 |
Financial position: |  |  |  |  |  |  |  |  |  |  |  |
Total assets |  | ¥ | 19,563,071 |  |  | ¥ | 26,689,362 |  |  | ¥ | 28,275,250 |
Total liabilities |  |  | 12,379,335 |  |  |  | 17,178,962 |  |  |  | 18,861,607 |
Total equity |  |  | 7,183,736 |  |  |  | 9,510,400 |  |  |  | 9,413,643 |
For information about significant transactions between the Company and its subsidiaries, and equity method investees except as described above, see Note 7 “Installment Loans” and Note 31 “Commitments, Guarantees and Contingent Liabilities.”

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. + References Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 323 -Publisher FASB -URI https://asc.fasb.org/323/tableOfContent + Details
Name: | us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration